Codexis (CDXS) Accumulated Expenses (2010 - 2026)
Codexis (CDXS) posted quarterly Accumulated Expenses of $5.4 million for Q1 2026, up 4.73% year-over-year from $5.1 million in Q1 2025, and down 51.47% quarter-over-quarter from $11.0 million in Q4 2025.
Codexis (CDXS) Accumulated Expenses (2010 - 2026) Analysis & Trends
Codexis' Accumulated Expenses history runs 17 years deep, the most recent figure standing at $5.4 million for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 4.73% year-over-year to $5.4 million; the TTM figure through Mar 2026 stood at $5.4 million (up 4.73% YoY), while the FY2025 annual figure was $11.0 million, up 77.44% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $5.4 million, down from $11.0 million in the prior quarter.
- The five-year high for Accumulated Expenses was $15.3 million in Q4 2022, with the low at $3.0 million in Q3 2025.
- The 5-year median for Accumulated Expenses is $8.3 million (2023), against an average of $8.3 million.
- The sharpest annual moves came in 2022 and 2025: Accumulated Expenses soared 88.57% in 2022, then tumbled 71.06% in 2025.
- Codexis' Accumulated Expenses stood at $15.3 million in 2022, then fell by 26.4% to $11.2 million in 2023, then sank by 44.66% to $6.2 million in 2024, then surged by 77.44% to $11.0 million in 2025, then slumped by 51.47% to $5.4 million in 2026.
- Business Quant data shows CDXS's Accumulated Expenses at $5.4 million in Q1 2026, $11.0 million in Q4 2025, and $3.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.32 Mn |
| Mar 31, 2026 | 5.36 Mn |
| Dec 31, 2025 | 11.04 Mn |
| Sep 30, 2025 | 2.99 Mn |
| Jun 30, 2025 | 7.26 Mn |
| Mar 31, 2025 | 5.12 Mn |
| Dec 31, 2024 | 6.22 Mn |
| Sep 30, 2024 | 10.32 Mn |
| Jun 30, 2024 | 5.42 Mn |
| Mar 31, 2024 | 5.37 Mn |
| Dec 31, 2023 | 11.25 Mn |
| Sep 30, 2023 | 8.80 Mn |
| Jun 30, 2023 | 8.54 Mn |
| Mar 31, 2023 | 8.34 Mn |
| Dec 31, 2022 | 15.28 Mn |
| Sep 30, 2022 | 9.46 Mn |
| Jun 30, 2022 | 12.93 Mn |
| Mar 31, 2022 | 6.84 Mn |
| Dec 31, 2021 | 12.58 Mn |
| Sep 30, 2021 | 15.93 Mn |